Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-08

Clinical Trial Update: Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial compared artificial tears with preservative-free ketorolac trometamol 0.45% for acute viral conjunctivitis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artificial Tears
  • Ketorolac trometamol 0.45% (preservative-free) (ketorolac trometamol)

Snippet

Sponsor: Fundação Altino Ventura | Conditions: Conjunctivitis, Viral | Phase 2, Phase 3 | Status: COMPLETED